1.Epidemiological Characteristics and Risk Factors of the Pertussis in Infants < 12 Months of Age in Tianjin, China.
Hai Tao HUANG ; Zhi Gang GAO ; Yong LIU ; Li Juan WANG ; Yan Ping LIU ; Ying ZHANG
Biomedical and Environmental Sciences 2017;30(7):545-548
The epidemiologic characteristics of 631 infant pertussis cases < 12 months, which accounted for 57.42% of the total cases, were analyzed by descriptive epidemiology in Tianjin, between 2010 and 2015. The incidence of infants was 104.66/100,000, which was 118 times higher than in other age groups (P < 0.001). The primary type of pertussis simultaneously presented in households was adult-to-infant (70.51%). The parents were identified as the source of infection in 80.18% of cases for infants. The positive rate of placental antibody transfer was 31.06% and 3.13% for 3-month-old infants. Infants presented the highest age-specific pertussis incidence. The most important reason was parents were the important sources of infection, and secondly the lower level of antibodies in neonates and the rapid waning of maternal antibody titer.
China
;
epidemiology
;
Female
;
Humans
;
Infant
;
Infant, Newborn
;
Male
;
Pertussis Vaccine
;
immunology
;
Risk Factors
;
Whooping Cough
;
epidemiology
;
prevention & control
;
transmission
2.Pertussis Prevalence in Korean Adolescents and Adults with Persistent Cough.
Soo Young LEE ; Seung Beom HAN ; Jin Han KANG ; Ju Sang KIM
Journal of Korean Medical Science 2015;30(7):988-990
We investigated the prevalence of pertussis in Korean adolescents and adults with persistent cough. Study population was adolescents (aged 11-20 yr) and adults (> or = 21 yr old) who showed persistent cough of 1-8 weeks' duration. Pertussis was diagnosed by culture, polymerase chain reaction (PCR), and serology. A total of 310 subjects participated in this study, and 76 cases (24.5%) met the criteria for laboratory-confirmed pertussis. The majority of the pertussis cases (66/76) were confirmed by serology, while 3 cases (1.0%) were diagnosed with culture, and 10 cases (3.2%) were detected with PCR. Of the 76 subjects diagnosed with pertussis, 20/86 cases were adolescents and 56/224 cases were adults. Neither adolescents nor adults received adolescent-adult booster against pertussis within the previous 5 yr. Pertussis can be a primary cause of persistent cough in Korean adolescents and adults.
Adolescent
;
Adult
;
Bordetella pertussis/immunology
;
Child
;
Cough/*epidemiology
;
Diphtheria-Tetanus-Pertussis Vaccine/immunology/*therapeutic use
;
Female
;
Humans
;
Immunization, Secondary/*utilization
;
Male
;
Republic of Korea/epidemiology
;
Whooping Cough/*epidemiology/immunology
;
Young Adult
3.Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G.
Soo Young LEE ; Seung Beom HAN ; E Young BAE ; Jong Hyun KIM ; Jin Han KANG ; Yeon Joon PARK ; Sang Hyuk MA
Journal of Korean Medical Science 2014;29(5):652-656
This study was conducted to evaluate age-specific seroprevalence of pertussis in Korea and to formulate a strategy to prevent and reduce the incidence of pertussis. Residual serum samples of healthy adolescents and adults 11 yr of age or older were collected between July 2012 and December 2012, and anti-pertussis toxin (PT) IgG titers were measured using a commercial ELISA kit. We compared the mean anti-PT IgG titers and seroprevalence of pertussis of the six age groups: 11-20, 21-30, 31-40, 41-50, 51-60, and > or = 61 yr. A total of 1,192 subjects were enrolled. The mean anti-PT IgG titer and pertussis seroprevalence were 35.53 +/- 62.91 EU/mL and 41.4%, respectively. The mean anti-PT IgG titers and seroprevalence were not significantly different between the age groups. However, the seroprevalence in individuals 51 yr of age or older was significantly higher than in individuals younger than 51 yr (46.5% vs 39.1%, P = 0.017). Based on these results, a new pertussis prevention strategy is necessary for older adults.
Adolescent
;
Adult
;
Aging
;
Antibodies, Bacterial/*blood
;
Bordetella pertussis/*immunology
;
Child
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Humans
;
Immunoglobulin G/*blood/immunology
;
Incidence
;
Male
;
Middle Aged
;
Pertussis Toxin/blood/*immunology
;
Pertussis Vaccine/immunology
;
Republic of Korea/epidemiology
;
Seroepidemiologic Studies
;
Vaccination
;
Whooping Cough/blood/*epidemiology
;
Young Adult
4.Seroepidemiology of pertussis in the adult population of Singapore.
Annelise WILDER-SMITH ; S NG ; Arul EARNEST
Annals of the Academy of Medicine, Singapore 2006;35(11):780-782
INTRODUCTIONPertussis is a highly communicable, vaccine-preventable respiratory disease and a frequent but often underestimated cause of prolonged cough illness in adults. Protection after childhood vaccination is minimal after 10 years without boosting. The need for adult booster depends on the national epidemiology.
MATERIALS AND METHODSWe did a seroepidemiological survey amongst the adult population (aged 18 to 45 years) of Singapore. None had received pertussis booster vaccine in the preceding 10 years. We measured IgG antibodies to pertussis whole cell antigen.
RESULTSTwo hundred and seventy subjects with the median age of 30 years were enrolled. We found positive IgG antibody levels in 97% of the population. Seropositivity was not associated with age, gender or race.
CONCLUSIONThe seroprevalence in adults was much higher than the previously documented seroprevalence of around 50% in the adolescent age group in Singapore. The increase is most likely due to natural infection with B. pertussis. Pertussis booster vaccine for adolescents/young adults in Singapore would be indicated.
Adolescent ; Adult ; Antibodies, Anti-Idiotypic ; immunology ; Antibodies, Bacterial ; blood ; Bordetella pertussis ; immunology ; Cross-Sectional Studies ; Diphtheria-Tetanus-acellular Pertussis Vaccines ; pharmacology ; Female ; Humans ; Immunoglobulin G ; immunology ; Male ; Middle Aged ; Population Surveillance ; methods ; Prevalence ; Prognosis ; Retrospective Studies ; Seroepidemiologic Studies ; Singapore ; epidemiology ; Whooping Cough ; epidemiology ; immunology ; prevention & control